Your Top 50 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

Five‐year efficacy and safety of tildrakizumab in patients with moderate‐to‐severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2)*

Diamant Thaçi, Stefano Piaserico, Richard Bruce Warren, Aditya Kumar Gupta, Wendy Cantrell, Zoe Diana Draelos and 10 more

Rank
12 of 851
Percentile
top 1.5%
Where
British Journal of Dermatology, 2021
Citations
103

From the 2021 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.